The S protein is the principal target of the COVID-19 vaccine; likewise, the majority of the serum-neutralizing antibody responses induced through spontaneous SARS-CoV-2 infections are concentrated on the RBD of the S protein [12,53,54]. Here, PROS1 is linked to COVID-19.